Organization | Beijing Municipal Health Bureau

Beijing Municipal Health Bureau Report issue

Government

Organization Overview

First Clinical Trial

2012

NCT02133469

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Active Ingredients

Drugs in Other Trials (5)

acetylsalicylic acid (aspirin) (1 trial)

cilostazol (pletal) (1 trial)

clopidogrel (plavix) (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)

pneumococcal 7-valent conjugate vaccine (Prevnar) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 5